Saturday - September 13, 2025
Goodwin Guides BeOne Medicines in IMDELLTRA Royalty Purchase Agreement for up to $950 Million
August 26, 2025
BOSTON, Massachusetts, Aug. 26 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:

* * *

Goodwin Guides BeOne Medicines in IMDELLTRA Royalty Purchase Agreement for up to $950 Million

*

The Life Sciences team advised BeOne Medicines Ltd on an agreement to sell its royalty rights on the worldwide sales, excluding China, of Amgen's IMDELLTRA(r) (tarlatamab-dlle) for up to $950 million to Royalty Pharma. Under t . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products